Other

Explore diverse learning prospects at our event, featuring open-access principles and opportunities to present and publish your work. Engage with leading academics and delve into contemporary topics shaping the future of social sciences and humanities.

Counsel patients with diabetes on cardiovascular disease prevention, Discuss the risks and benefits of SGLT-2 Inhibitors, Understand the risks and benefits of Incretin (GLP-1, GIP) medications used in type 2 diabetes mellitus

The program will feature state-of-the-art lectures, case presentations, and interactive sessions tailored to address educational needs in global healthcare settings. Ample time is reserved for debates and panel discussions to enhance knowledge exchange and reinforce the implementation of clinical guidelines and recommendations

With a brand new 2 tracked agenda, hear in-depth presentations across preclinical development vs clinical strategy to gain the insights needed to boost candidates among industry pioneers

The 2nd International Conference on Social Sciences in the Modern Era provides a platform for scholars and professionals to stay updated, network, and shape discourse. Attendees will engage in insightful lectures, poster presentations, and discussions on trends, challenges, and long-term projects in social sciences.

This course will add tremendous value to residents in training as well as fellows in multiple specialties, including family practice, internal medicine, pediatrics, neurology, neurosurgery, medical oncology, radiation oncology, radiology, and pathology.

he program will explore how to overcome barriers to immune cell entry into tumors, as well as insufficient activation of anti-tumor immune responses. In addition, diverse immune cell therapies will be covered, from T-cell based mainstays like TILs, gene-modified T cells, and CAR-T cells, to emerging modalities deploying innate immune cells like dendritic and NK cells.

The cutting-edge AACR IO 2025 program will appeal to a wide audience of basic scientists, translational researchers, clinical investigators, regulators, industry, investors, and lay press. A mix of keynote lectures, major symposia, spotlight sessions, educational sessions, special sessions, and poster sessions with exhibits will cover the spectrum of the IO field – including late-breaking clinical trials sessions highlighting new agents and IO combinations, and the results of practice-changing.

The program consists of engaging lectures with relevant case presentations by experts; there will be discussions and analysis of the pre-assignment documents and demonstration of good documentation practices, including voice recognition technology; and a Q&A session where individual questions are addressed. The course culminates with small group sessions in which expert coding preceptors discuss improvement opportunities discovered in the submitted patient records provided by the participants.

The symposium will also include the opportunity for trainees to present original research during abstract presentation sessions. The symposium is designed to showcase original research in vaccinology, vaccine science, pathogenesis, and immunology. The symposium honors Dr. Kathryn Edwards, a leader in vaccinology and infectious diseases.

The management of lung cancer is becoming increasingly intricate, driven by the remarkable advancements in immunotherapy, targeted therapy, and innovative treatments. Learn how to effectively utilize these therapies directly from the researchers pioneering these advancements